Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Biohaven Pharmaceutical Holding Co Ltd (Symbol: BHVN), where a total of 4,114 contracts have traded so far, representing approximately 411,400 underlying shares. That amounts to about 77.6% of BHVN's average daily trading volume over the past month of 530,035 shares. Particularly high volume was seen for the $75 strike call option expiring January 17, 2020, with 1,870 contracts trading so far today, representing approximately 187,000 underlying shares of BHVN. Below is a chart showing BHVN's trailing twelve month trading history, with the $75 strike highlighted in orange:
BioMarin Pharmaceutical Inc. (Symbol: BMRN) saw options trading volume of 10,102 contracts, representing approximately 1.0 million underlying shares or approximately 76.6% of BMRN's average daily trading volume over the past month, of 1.3 million shares. Particularly high volume was seen for the $90 strike call option expiring June 21, 2019, with 4,458 contracts trading so far today, representing approximately 445,800 underlying shares of BMRN. Below is a chart showing BMRN's trailing twelve month trading history, with the $90 strike highlighted in orange:
And Ashland Global Holdings Inc (Symbol: ASH) saw options trading volume of 7,251 contracts, representing approximately 725,100 underlying shares or approximately 75.2% of ASH's average daily trading volume over the past month, of 964,150 shares. Particularly high volume was seen for the $80 strike call option expiring July 19, 2019, with 2,404 contracts trading so far today, representing approximately 240,400 underlying shares of ASH. Below is a chart showing ASH's trailing twelve month trading history, with the $80 strike highlighted in orange:
For the various different available expirations for BHVN options, BMRN options, or ASH options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
